PLC Systems begins second bid for transmyocardial revascularisation (TMR) laser approval
This article was originally published in Clinica
Executive Summary
PLC Systems has begun submitting supplementary patient data to the FDA on the use of its Heart Laser System for transmyocardial revascularisation (TMR).